NewAmsterdam Pharma Company NV - Warrants (15/11/2027) Total Liabilities

As of the most recent data (June 2026), NAMSW shows a total liabilities of $73M. That compares with $37M in the prior-year period — up 99.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NAMSW's total liabilities is now $73M (was $37M) — a 99.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether NewAmsterdam Pharma Company NV - Warrants (15/11/2027) is outperforming or lagging.

Tracking NAMSW's total liabilities over time shows whether NewAmsterdam Pharma Company NV - Warrants (15/11/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $73M That compares with $37M in the prior-year period — up 99.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has NewAmsterdam Pharma Company NV - Warrants (15/11/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $73M) with ownership activity and broader fundamentals.